Cargando…

Machine learning model for the prediction of prostate cancer in patients with low prostate-specific antigen levels: A multicenter retrospective analysis

OBJECTIVE: The aim of this study was to develop a predictive model to improve the accuracy of prostate cancer (PCa) detection in patients with prostate specific antigen (PSA) levels ≤20 ng/mL at the initial puncture biopsy. METHODS: A total of 146 patients (46 with Pca, 31.5%) with PSA ≤20 ng/mL who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Xiaobin, Li, Tianyu, Mo, Linjian, Wang, Fubo, Ji, Jin, He, Xing, Mohamud, Bashir Hussein, Pradhan, Swadhin, Cheng, Jiwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433549/ https://www.ncbi.nlm.nih.gov/pubmed/36059701 http://dx.doi.org/10.3389/fonc.2022.985940

Ejemplares similares

Development, comparison, and validation of four intelligent, practical machine learning models for patients with prostate-specific antigen in the gray zone
por: Liu, Taobin, et al.
Publicado: (2023)

Isolated brain metastasis of prostate carcinoma in the setting of normal prostate specific antigen
por: Campagna, Justin P., et al.
Publicado: (2018)

Prostate-Specific Antigen Bounce Following Stereotactic Body Radiation Therapy for Prostate Cancer
por: Vu, Charles C., et al.
Publicado: (2014)

Prostate-Specific Membrane Antigen Uptake and Survival in Metastatic Castration-Resistant Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Focal therapy of prostate cancer: Assessment with prostate-specific membrane antigen (PSMA) imaging
por: Topoozian, Mark, et al.
Publicado: (2023)

Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
por: Xu, Bei, et al.
Publicado: (2021)

Combining prostate-specific antigen density with prostate imaging reporting and data system score version 2.1 to improve detection of clinically significant prostate cancer: A retrospective study
por: Lei, Yin, et al.
Publicado: (2022)

New Prostate Cancer Targets for Diagnosis, Imaging, and Therapy: Focus on Prostate-Specific Membrane Antigen
por: Cimadamore, Alessia, et al.
Publicado: (2018)

Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
por: Cheng, Yung-Ting, et al.
Publicado: (2022)

The role of prostate-specific antigen in the osteoblastic bone metastasis of prostate cancer: a literature review
por: Zhang, Xu, et al.
Publicado: (2023)

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
por: MacKintosh, F. Roy, et al.
Publicado: (2016)

Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review
por: Vernooij, Robin W M, et al.
Publicado: (2018)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
por: Mandel, Philipp, et al.
Publicado: (2021)

Survival in Patients With Metastatic Prostate Cancer Undergoing Radiotherapy: The Importance of Prostate-Specific Antigen-Based Stratification
por: Tian, Zijian, et al.
Publicado: (2021)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
por: Karnes, R. Jeffrey, et al.
Publicado: (2018)

PI-RADS v2.1 Combined With Prostate-Specific Antigen Density for Detection of Prostate Cancer in Peripheral Zone
por: Wen, Jing, et al.
Publicado: (2022)

Machine Learning-Based Prediction of Pathological Upgrade From Combined Transperineal Systematic and MRI-Targeted Prostate Biopsy to Final Pathology: A Multicenter Retrospective Study
por: Zhuang, Junlong, et al.
Publicado: (2022)

Expression of Prostate-Specific Membrane Antigen (PSMA) on Biopsies Is an Independent Risk Stratifier of Prostate Cancer Patients at Time of Initial Diagnosis
por: Hupe, Marie Christine, et al.
Publicado: (2018)

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018)

Prostate-Specific Antigen 5 Years following Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: An Ablative Procedure?
por: Kataria, Shaan, et al.
Publicado: (2017)

Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen?
por: Faviana, Pinuccia, et al.
Publicado: (2021)

Differences in Prostate Cancer Incidence and Mortality in Lower Saxony (Germany) and Groningen Province (Netherlands): Potential Impact of Prostate-Specific Antigen Testing
por: Kappen, Sanny, et al.
Publicado: (2021)

Prostate-specific membrane antigen-based imaging for stereotactic irradiation of low-volume progressive prostate cancer: a single-center experience
por: Varga, Linda, et al.
Publicado: (2023)

Single-Cell RNA Sequencing of Metastatic Testicular Seminoma Reveals the Cellular and Molecular Characteristics of Metastatic Cell Lineage
por: Mo, Linjian, et al.
Publicado: (2022)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

The Spontaneous Remission of Recurrent Lymph Node Metastatic Prostate Cancer With Lowering Serum Prostate-Specific Antigen Level
por: Katano, Atsuto, et al.
Publicado: (2022)

Urine Exosomal AMACR Is a Novel Biomarker for Prostate Cancer Detection at Initial Biopsy
por: Jin, Xin, et al.
Publicado: (2022)

Machine Learning-Based Models Enhance the Prediction of Prostate Cancer
por: Chen, Sunmeng, et al.
Publicado: (2022)

Machine learning methods can more efficiently predict prostate cancer compared with prostate-specific antigen density and prostate-specific antigen velocity
por: Nitta, Satoshi, et al.
Publicado: (2019)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Treatment of Advanced Metastatic Prostate Cancer Using Molecular-Targeted Therapy: Radioligand Lutetium-177 Prostate-Specific Membrane Antigen
por: Rathore, Rajni, et al.
Publicado: (2023)

Variation in the Use of Active Surveillance for Low-Risk Prostate Cancer Across US Census Regions
por: Al Hussein Al Awamlh, Bashir, et al.
Publicado: (2021)

Survival Significance of Patients With Low Prostate-Specific Antigen and High-Grade Prostate Cancer After Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy
por: Guo, Yadong, et al.
Publicado: (2019)

Incidence and associated factors for incidental prostate cancer among patients who underwent surgery for benign prostatic hyperplasia: first report from Somalia
por: Mohamed, Abdikarim Hussein, et al.
Publicado: (2022)

A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
por: Li, Yun, et al.
Publicado: (2021)

Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System
por: da Silva, Anna Carolina Borges, et al.
Publicado: (2023)

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer
por: Tagawa, Scott T., et al.
Publicado: (2013)

Targeted Alpha Therapy in mCRPC (Metastatic Castration-Resistant Prostate Cancer) Patients: Predictive Dosimetry and Toxicity Modeling of (225)Ac-PSMA (Prostate-Specific Membrane Antigen)
por: Belli, Maria Luisa, et al.
Publicado: (2020)

Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis
por: Hu, Mingqiu, et al.
Publicado: (2023)

Small Cell Cancer of the Bladder and Prostate: A Retrospective Review from a Tertiary Cancer Center
por: Ahmed, Shahida, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dma4j3agkk8bd2a4nq56n88jfg